PharmaCore Solutions

Pharmaceutical

Global pharmaceutical company focused on developing treatments for rare diseases.

PharmaCore Solutions has been a pioneer in rare disease treatment for over 25 years. We specialize in developing innovative therapies for conditions that affect small patient populations but have significant unmet medical needs. Our global reach and extensive research capabilities make us a leader in orphan drug development.

Founded

1995

Owner

Dr. Michael Rodriguez

Place

Basel, Switzerland

Our Products

HeartGuard Plus
Cardiology
Advanced cardiac protection medication for high-risk patients with proven efficacy.
Phase Commercial
Available
RareDisease-X
Rare Diseases
First-in-class treatment for ultra-rare metabolic disorders.
Phase III
Under Review
NeuroProtect
Neurology
Neuroprotective therapy for rare neurological conditions.
Phase II
Clinical Trial